Evidence map›Paper›PMID 33030593›Full record

ArticlePsychopharmacology2021

Protective effect of 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione, isolated from Averrhoa carambola L., against Aβ1-42-induced apoptosis in SH-SY5Y cells by reversing Bcl-2/Bax ratio.

Shunyu Lu, Xiaojie Wei, Hongliang Zhang, Zhenfeng Chen, Juman Li, Xiaohui Xu, Qiuqiao Xie, Lixiu Chen, Fangxing Ye, Hoa Thi Thai Phama and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Aloe emodin attenuates AβOpen medicine (Warsaw, Poland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Shunyu Lu *Department of Pharmacy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.
Xiaojie Wei *Department of Physiology, Faculty of Basic Medicine, Guangxi University of Chinese Medicine, Nanning, 530000, People's Republic of China.
Hongliang ZhangDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Zhenfeng Chen *State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin, 541004, People's Republic of China.
Juman LiDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Xiaohui XuDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Qiuqiao XieDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Lixiu ChenDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Fangxing YeDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Hoa Thi Thai PhamaDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Luhui JiangDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Tianmin HuangDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China.
Jinbin WeiDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China. jbwei@sina.cn.
Renbin HuangDepartment of Pharmacology, Guangxi Medical University, Nanning, 530021, People's Republic of China. huangrenbin518@163.com.
Guangxi Medical University · CNGuangxi Normal University · CNGuangxi University of Chinese Medicine · CNTumor Hospital of Guangxi Medical University · CN

Funding

National Natural Science Foundation of China 81460205, 81360129, 81160533, 81760665
6 · The paper itself

Abstract

background and purposeAβ1-42-induced neurotoxicity has been considered as a possible mechanism to aggravate the onset and progression of Alzheimer's disease (AD). In this study, we aim to determine the protective effect of DMDD on the apoptosis of SH-SY5Y cells induced by Aβ1-42 and elucidate potential mechanism of DMDD's protective function in apoptosis. EXPERIMENTAL APPROACH: CCK-8, AnnexinV-FITC/PI flow cytometry, and transmission electron microscopy analysis were used to determine the protection of DMDD on Aβ1-42-evoked apoptosis of SH-SY5Y cells. Cytochrome c release, JC-1 staining, and measuring the protein of Bcl-2 family by Western blot were applied to elucidate the mechanism of DMDD's protective function in apoptosis. KEY

resultsThree concentration of DMDD (5 μmol/L, 10 μmol/L, and 20 μmol/L) rescues the cell viability loss and apoptosis of SH-SY5Y cells cultivated in Aβ1-42. The expressions of cleaved Caspase-3, -8, -9, the cytochrome c release, and mitochondrial membrane potential loss were inhibited by DMDD in Aβ1-42-insulted SH-SY5Y cells. The Western blot analysis showed that DMDD pretreatment clearly downregulated the protein of Bax and upregulated Bcl-2. Moreover, the Bcl-2/Bax ratio was obviously decreased in cells only exposed to Aβ1-42, but, which was suppressed by treated with DMDD. CONCLUSION AND IMPLICATIONS: DMDD attenuated the apoptosis of SH-SY5Y cells induced by Aβ1-42 through reversing the Bcl-2/Bax ratio.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesApoptosisAverrhoabcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell SurvivalCyclohexenesDrugs, Chinese HerbalHumansMembrane Potential, MitochondrialPeptide FragmentsProto-Oncogene Proteins c-bcl-22-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dioneAmyloid beta-Peptidesamyloid beta-protein (1-42)BAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanCaspase 3CyclohexenesDrugs, Chinese HerbalPeptide FragmentsProto-Oncogene Proteins c-bcl-22-Dodecyl-6-methoxycyclohexa-24-Dione; Amyloid β-peptides 1–425-Diene-1Alzheimer’s diseaseBcl-2/Bax

Identifiers

PMID33030593
OpenAlexW3092103407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.